Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, EpiSciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Journal articles

Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro

Abstract : Background: Iodine contrast agents (ICAs) are routinely used by radiologists to help guide intra-articular infiltrations. The aim of this study was to assess the in vitro effects of ICA on platelet function of human autologous Platelet-Rich Plasma (PRP). Methods: One hundred thirty-seven consecutive patients with symptomatic femoral-patellar osteoarthritis were included. All were addressed to our institution for a fluoroscopy-guided intra-articular PRP infiltration of the pathological femoral-patellar joint. For each patient, 500 μl of PRP were sampled before intra-articular injection. First, PRP samples were mixed with 50 μl of 2 widely used ICA: Visipaque270® (Iodixanol, n = 58) and Iopamiron200® (Iopamidol, n = 69). PRP concentration ([PRP]) was measured at different delays of incubation (t = 0, 5, 10, 15, 20 and 30 min) enabling to calculate PRP ratio (defined as [PRP](t)/[PRP](0mn)) at each delay, for each mixture, in order to quantitatively assess the influence of ICA on PRP ratio. Second, the PRP samples of 10 additional patients were mixed with Visipaque270®, Visipaque270®, Iopamiron200® and phosphate buffer saline (PBS: control solution) in order to qualitatively assess the influence of ICA on platelet aggregation, using ADP, Collagen, Arachidonic acid and TRAP tests. The surface expression of human P-selectin, a marker of α-granule release, in the PRP + Visipaque270® and PRP + Iopamiron200® mixtures was finally compared. Repeated-measures ANOVA, classical 2-way ANOVA and Wilcoxon matched-pairs test were used to study the influence of ICA on PRP quality. Results: There was no significant change in PRP ratio during the first 30mn of incubation (p = 0.991) whatever the ICA (p = 0.926). Whatever the aggregation test, there was no significant difference in the percentage of platelet aggregation between PRP + PBS, PRP + Visipaque270® and PRP + Iopamiron200® (p = 0.998), nor between PRP + PBS and PRP + Visipaque320® (p = 0.470). Finally, there was no significant difference in P-selectin expression between the PRP + Visipaque270® and PRP + Iopamiron200® mixtures (p = 0.500). Conclusion: At early delays of incubation, Visipaque® and Iopamiron®, which are two widely used ICA for intra-articular infiltrations, did not influence the in vitro platelet function nor the quality of PRP.
Complete list of metadata

Cited literature [25 references]  Display  Hide  Download

https://hal-cnrs.archives-ouvertes.fr/hal-02421036
Contributor : Karine VIAUD Connect in order to contact the contributor
Submitted on : Friday, December 20, 2019 - 11:26:22 AM
Last modification on : Monday, March 28, 2022 - 10:34:02 AM
Long-term archiving on: : Saturday, March 21, 2020 - 3:22:10 PM

File

40634_2018_Article_162(1).pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

B. Dallaudière, A. Crombé, A. P Gadeau, L. Pesquer, A. Peuchant, et al.. Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro. Journal of Experimental Orthopaedics, Springer Verlag, 2018, 5, pp.47. ⟨10.1186/s40634-018-0162-4⟩. ⟨hal-02421036⟩

Share

Metrics

Record views

33

Files downloads

43